[DPHARMA] YoY Cumulative Quarter Result on 30-Jun-2017 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
25-Aug-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
30-Jun-2017 [#2]
Profit Trend
QoQ- 122.99%
YoY- 55.65%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 302,044 295,852 257,250 240,355 158,605 101,907 81,118 24.47%
PBT 37,118 37,102 26,170 24,764 17,664 20,605 21,302 9.68%
Tax -8,828 -8,721 -5,184 -5,559 -5,895 -5,788 -5,410 8.49%
NP 28,290 28,381 20,986 19,205 11,769 14,817 15,892 10.07%
-
NP to SH 28,290 28,381 20,986 19,217 12,346 14,817 15,892 10.07%
-
Tax Rate 23.78% 23.51% 19.81% 22.45% 33.37% 28.09% 25.40% -
Total Cost 273,754 267,471 236,264 221,150 146,836 87,090 65,226 26.97%
-
Net Worth 581,725 503,029 209,983 463,071 446,334 190,284 179,045 21.67%
Dividend
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Div 3,421 6,618 4,199 6,973 6,973 5,596 5,551 -7.74%
Div Payout % 12.10% 23.32% 20.01% 36.29% 56.49% 37.77% 34.93% -
Equity
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Net Worth 581,725 503,029 209,983 463,071 446,334 190,284 179,045 21.67%
NOSH 684,383 661,881 650,902 278,959 278,959 139,915 138,794 30.43%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin 9.37% 9.59% 8.16% 7.99% 7.42% 14.54% 19.59% -
ROE 4.86% 5.64% 9.99% 4.15% 2.77% 7.79% 8.88% -
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
RPS 44.13 44.70 91.88 86.16 56.86 72.83 58.44 -4.56%
EPS 4.13 4.26 3.22 6.88 4.22 10.59 11.45 -15.61%
DPS 0.50 1.00 1.50 2.50 2.50 4.00 4.00 -29.26%
NAPS 0.85 0.76 0.75 1.66 1.60 1.36 1.29 -6.71%
Adjusted Per Share Value based on latest NOSH - 278,959
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
RPS 31.40 30.76 26.74 24.99 16.49 10.59 8.43 24.47%
EPS 2.94 2.95 2.18 2.00 1.28 1.54 1.65 10.09%
DPS 0.36 0.69 0.44 0.72 0.72 0.58 0.58 -7.63%
NAPS 0.6047 0.5229 0.2183 0.4814 0.464 0.1978 0.1861 21.68%
Price Multiplier on Financial Quarter End Date
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Date 30/06/20 28/06/19 29/06/18 30/06/17 30/06/16 30/06/15 30/06/14 -
Price 1.62 1.37 1.30 2.25 2.04 2.65 2.97 -
P/RPS 3.67 3.06 1.41 2.61 3.59 3.64 5.08 -5.26%
P/EPS 39.19 31.95 17.34 32.66 46.09 25.02 25.94 7.11%
EY 2.55 3.13 5.77 3.06 2.17 4.00 3.86 -6.67%
DY 0.31 0.73 1.15 1.11 1.23 1.51 1.35 -21.72%
P/NAPS 1.91 1.80 1.73 1.36 1.28 1.95 2.30 -3.04%
Price Multiplier on Announcement Date
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Date 13/08/20 30/08/19 26/11/18 25/08/17 22/08/16 25/08/15 26/08/14 -
Price 3.15 1.41 1.08 2.03 2.14 2.40 3.37 -
P/RPS 7.14 3.15 1.18 2.36 3.76 3.30 5.77 3.61%
P/EPS 76.20 32.88 14.41 29.47 48.35 22.66 29.43 17.16%
EY 1.31 3.04 6.94 3.39 2.07 4.41 3.40 -14.68%
DY 0.16 0.71 1.39 1.23 1.17 1.67 1.19 -28.40%
P/NAPS 3.71 1.86 1.44 1.22 1.34 1.76 2.61 6.03%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment